CME-CPD

Educational objectives

After participating in this educational activity, participants should be able to:

• Demonstrate the techniques and utility of advanced cardiac ultrasound
• Integrate Doppler ultrasound principles for pressure and cardiac output estimation using advanced Focus Assessed Transthoracic Echocardiography (FATE)
• Apply diastology of the heart into clinical practice
• Evaluate lung pathologies using integrated cardiac and lung ultrasound
• Assess intracranial pathologies using ocular and transcranial ultrasound
• Estimate fluid and hemodynamic status
• Assess systemic congestion using venous doppler ultrasound
• Utilize a variety of ultrasound machines to learn advanced POCUS
• Predict the limitations of cardiac ultrasound
• Practice advanced point of care ultrasound for enhanced patient care

---

Target audience

This much-anticipated advanced POCUS course is a master skills live immersion course designed for the physician learner and requested by those who have completed the ASRA Pain Medicine Introduction to Perioperative Point-of-Care Ultrasound course. Prior completion of the introduction course or an equivalent knowledge and level of practice is a prerequisite for this course. If you have any questions about whether this course is right for you, please send your questions to asrameetings@asra.com. We are happy to find the best course to meet your needs.

---

Accreditation and credit designation statements

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Society of Regional Anesthesia and Pain Medicine and UltraSound of Airway, Breathing, Circulation and Dolor (USabcd). The American Society of Regional Anesthesia and Pain Medicine is accredited by the ACCME to provide continuing medical education for physicians. 

The American Society of Regional Anesthesia and Pain Medicine designates this other activity (blended eLearning and live course) for a maximum of 25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

---

The American Board of Anesthesiology^® MOCA^®

This activity contributes to the CME requirements for Part II: Lifelong Learning and Self-Assessment of the American Board of Anesthesiology’s (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0™. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements. Maintenance of Certification in Anesthesiology Program® and MOCA® are registered certification marks of The American Board of Anesthesiology®. 

ASRA Pain Medicine is an ABA-approved provider and, as a service to ASRA Pain Medicine members and participants, CME credits are reported to the ABA. Participants must include their correctly formatted ABA ID number (34567890) during the online evaluation and credit claim process available at the conclusion of the activity. Once the online evaluation and credit claim process is closed, certificates will be issued and credits reported to the ABA. After this time, participants may request their CME certificate by contacting asrameetings@asra.com, but ASRA Pain Medicine will no longer report credits to the ABA, which will then be the individual participant’s responsibility. 

---

International credits

Royal College of Physicians and Surgeons of Canada: The Royal College of Physicians and Surgeons of Canada has agreements based on the mutual recognition of credit points with the American Medical Association for live and web-based (synchronous or asynchronous) educational events. You may submit your CME certificate directly for credit recognition of this accredited group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada. For more information, visit: www.royalcollege.ca 

European Accreditation Council for Continuing Medical Education (UEMS-EACCME): The UEMS-EACCME has agreements based on the mutual recognition of credit points with the American Medical Association for live and e-learning educational events. Each medical specialist should claim only those hours of credit that they actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS): www.uems.net

---

Commercial support disclosure

Click here to view all industry support. This course is supported, in part, by in-kind support from industry. All support is managed in strict accordance with the ACCME’s Standards for Integrity and Independence. Appropriate acknowledgment of all supporting organizations is made to participants prior to the educational activity on the event website and with signage during the meeting. View the guidelines for company representative and in-kind support. 

ASRA Pain Medicine thanks the following organizations for their generous support: 

• Durable equipment: FUJIFILM SonoSite, GE Healthcare, Mindray, Philips Healthcare
• Disposable supplies: CIVCO Medical Solutions

---

Disclosure and mitigation of personal conflicts of interest

Click here to view all faculty disclosures. In accordance with the ACCME’s Standards for Integrity and Independence and related policies, ASRA Pain Medicine is committed to ensuring balance, independence, objectivity, and scientific rigor in its continuing medical education and continuing professional development activities. Those in control of the educational content disclose all relationships (financial or other) with any ineligible company that they have had within the past 24 months. If an individual refuses to disclose, they are disqualified from participating. Disclosure information is evaluated to determine relevance and conflicts of interest mitigated. Disclosure of all relevant financial relationships is made to participants prior to the activity. Participants are asked to evaluate the objectivity and independence. Off-label or investigational use of a therapeutic product also is disclosed.